ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Bristol Dedicates New Research center; MSK Presents Awards to Sen. Moyniham, 10 Others

July 11, 1986

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

An Adult Surgery Adapted To Children Increased Survival Of Rare Abdominal Cancer

May 28, 2010

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007